Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

An identity crisis for fps/fes: oncogene or tumor suppressor?

Sangrar W, Zirgnibl RA, Gao Y, Muller WJ, Jia Z, Greer PA.

Cancer Res. 2005 May 1;65(9):3518-22.

2.
3.

Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.

Greer P, Maltby V, Rossant J, Bernstein A, Pawson T.

Mol Cell Biol. 1990 Jun;10(6):2521-7.

4.
5.

fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of E-cadherin-based adherens junctions in breast epithelial cells during lactation.

Truesdell PF, Zirngibl RA, Francis S, Sangrar W, Greer PA.

Exp Cell Res. 2009 Oct 15;315(17):2929-40. doi: 10.1016/j.yexcr.2009.08.021. Epub 2009 Sep 2.

PMID:
19732771
6.

Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation.

Senis YA, Sangrar W, Zirngibl RA, Craig AW, Lee DH, Greer PA.

J Thromb Haemost. 2003 May;1(5):1062-70.

7.

Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.

Senis Y, Zirngibl R, McVeigh J, Haman A, Hoang T, Greer PA.

Mol Cell Biol. 1999 Nov;19(11):7436-46.

8.

The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice.

Greer P, Haigh J, Mbamalu G, Khoo W, Bernstein A, Pawson T.

Mol Cell Biol. 1994 Oct;14(10):6755-63.

9.

Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Yee SP, Mock D, Greer P, Maltby V, Rossant J, Bernstein A, Pawson T.

Mol Cell Biol. 1989 Dec;9(12):5491-9.

11.

A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.

Delfino FJ, Stevenson H, Smithgall TE.

J Biol Chem. 2006 Mar 31;281(13):8829-35. Epub 2006 Feb 2.

12.

Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor.

Feldman RA, Lowy DR, Vass WC.

Oncogene Res. 1990;5(3):187-97.

PMID:
2157188
13.

Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival.

Sangrar W, Gao Y, Bates B, Zirngibl R, Greer PA.

Exp Hematol. 2004 Oct;32(10):935-45.

PMID:
15504549
14.

Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).

Hjermstad SJ, Peters KL, Briggs SD, Glazer RI, Smithgall TE.

Oncogene. 1993 Aug;8(8):2283-92.

PMID:
7687763
15.

Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.

Roebroek AJ, Schalken JA, Onnekink C, Bloemers HP, Van de Ven WJ.

J Virol. 1987 Jun;61(6):2009-16.

16.
17.

The contrasting oncogenic and tumor suppressor roles of FES.

Greer PA, Kanda S, Smithgall TE.

Front Biosci (Schol Ed). 2012 Jan 1;4:489-501. Review.

PMID:
22202072
19.
20.

Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells.

Haigh JJ, Ema M, Haigh K, Gertsenstein M, Greer P, Rossant J, Nagy A, Wagner EF.

Blood. 2004 Feb 1;103(3):912-20. Epub 2003 Oct 2.

Items per page

Supplemental Content

Write to the Help Desk